Command Palette

Search for a command to run...

boston-bio-systems

8.19+0.00%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Boston Bio Systems Ltd. is significantly underperforming compared to its peers, as evidenced by its negative PE ratio, zero revenue growth, and lack of profitability metrics. Among its peers, Poly Medicure Ltd. stands out as the leader in profitability and growth, while several companies exhibit concerning financial weaknesses, such as high PE ratios without corresponding earnings.

Key Points
  • Boston Bio Systems Ltd. shows no growth and poor financial metrics, placing it at a disadvantage.
  • Poly Medicure Ltd. demonstrates strong revenue growth and profitability, making it a standout performer.
  • Laxmi Dental Ltd. has a very high ROE but is also overvalued with a high PE ratio.
  • Several companies exhibit signs of financial weakness, particularly those with inflated PE ratios and low revenue growth.
Top Performers
Poly Medicure Ltd.

Highest revenue growth, strong profitability metrics, and reasonable debt levels.

Prevest Denpro Ltd.

Solid ROE and low debt, indicating good financial health despite lower growth.

Laxmi Dental Ltd.

High ROE, but high PE ratio indicates potential overvaluation.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.